🇺🇸 FDA
Pipeline program

Cefazolin with Daptomycin

202301864A3

Unknown small_molecule active

Quick answer

Cefazolin with Daptomycin for Periprosthetic Joint Infection is a Unknown program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Periprosthetic Joint Infection
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials